Table 3 Sensitivity analysis of prices of ACT, RDT and monotherapy
From: Optimal price subsidies for appropriate malaria testing and treatment behaviour
ACT price | RDT price | Monotherapy price | |||||||
|---|---|---|---|---|---|---|---|---|---|
ACT % | RDT % | Cost | ACT % | RDT % | Cost | ACT % | RDT % | Cost | |
Best estimate | 68.3 | 82.9 | 2.69 | 68.3 | 82.9 | 2.69 | 68.3 | 82.9 | 2.69 |
Lowest bound | −11.0 | 82.9 | 1.44 | 68.3 | 38.4 | 1.39 | No solution | No solution | No solution |
Highest bound | 88.9 | 82.9 | 5.94 | 68.3 | 89.5 | 3.82 | 51.1 | 67.9 | 2.12 |